AI steps in to protect transplanted kidneys
NCT ID NCT05432765
Summary
This pilot study is testing whether a computer system using artificial intelligence (AI) can help doctors find the best doses of anti-rejection drugs for people who have received a kidney transplant. The goal is to protect the new kidney from damage while using the lowest effective drug doses. The study will enroll 34 adult transplant recipients to compare the AI-guided dosing approach to standard doctor-led care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT REJECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health Shands
Gainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.